Home > Insider Trading > Filing (0000899243-20-006807)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1723128	Amneal Pharmaceuticals Inc.	AMRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1774807	Joseph Todisco	C/O Amneal Pharmaceuticals, Inc. 400 Crossing Boulevard, 3Rd Floor Bridgewater NJ 08807	Svp, Specialty Commercial	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2020-02-28	40,000	$3.62	246,845	No	4	P	Direct
Class A Common Stock	Acquisiton	2020-03-01	11,111	$0.00	257,956	No	4	M	Direct
Class A Common Stock	Disposition	2020-03-01	6,162	$3.85	251,794	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Restricted Stock Units	Disposition	2020-03-01	11,111	$0.00	11,111	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
33,333			No	4	M	Direct

Footnotes

Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
On March 1, 2019, the reporting person was granted 44,444 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.